<DOC>
	<DOC>NCT01383486</DOC>
	<brief_summary>A pilot trial to demonstrate that consumers can appropriately select Aleve 24 Hour for their own use based on expected duration of pain greater than 12 hours.</brief_summary>
	<brief_title>Self Selection Trial of Naproxen Sodium</brief_title>
	<detailed_description />
	<mesh_term>Naproxen</mesh_term>
	<criteria>At least 12 years of age Report taking at least one dose of Overthecounter (OTC) analgesic for pain in the past month Able to read and understand English Provide written informed consent (subjects 1217 years of age provide written assent and/or parent or legal guardian provide written consent) Provide contact information Have participated in a trial involving OTC analgesics in the last 6 months They or someone else in the household work for a market research company, an advertising agency, a public relations firm, a pharmaceutical company, as a healthcare professional, or as part of a health care practice (eliminated for reasons of confidentiality or increased awareness of drugs and their labels) Have a history of known allergies to Nonsteroidal Antiinflammatory Drugs (NSAIDs) (i.e., naproxen, ibuprofen, acetaminophen, aspirin, etc.) Have a history of heart surgery in the last 60 days or plans for heart surgery in the next 60 days Female subjects who have a positive urine pregnancy test or who are breastfeeding.</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Self Selection Tria</keyword>
</DOC>